Archives of Toxicology (2023) 97:1613–1626 https://doi.org/10.1007/s00204-023-03488-2

The author wish to disclose a typographical error in the abstract and the introduction in our recent publication referenced above. In both instances the abbreviation MeIQ was incorrectly defined as 2-amino-3,4,8-trimethylimidazo[4,5-f]quinoxaline.

The correct definition of MeIQ is 2-amino-3,4-dimethylimidazo[4,5-f]quinoline, as correctly indicated in Fig. 1.